EJNMMI Research

Table 1 Side effects of intracavitary Radioimmunotherapy according to CTCAE criteria (version 5.0)

From: First clinical experience with fractionated intracavitary radioimmunotherapy using [¹⁷⁷Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study

	Patient 1			Patient 2			Patient 3
	Baseline	After one cycle	After all cycles	Baseline	After one cycle	After all cycles	Baseline	After one cycle	After all cycles
Leukocytes	II	II	I	0	0	0	0	0	0
Hemoglobin	I	I	I	0	0	0	I	I	I
Platelets	I	I	I	0	0	0	0	0	0
Creatinine	0	0	0	0	0	0	0	0	0
Liver function	0	0	0	0	0	0	0	0	0
Creatinine	0	0	0	0	0	0	0	0	0
GFR	0	0	0	0	0	0	0	0	0

Significant changes are marked in bold

Back to article page